[1]程贵胜,彭彩霞,许 莺,等.基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的研究[J].医学信息,2024,37(07):120-123.[doi:10.3969/j.issn.1006-1959.2024.07.023]
　CHENG Gui-sheng,PENG Cai-xia,XU Ying,et al.Study on Clinical Observation and Pharmaceutical Care of Patients with Chronic Heart Failure Based on the Platform of Clinical Pharmacists and Medical Alliance[J].Journal of Medical Information,2024,37(07):120-123.[doi:10.3969/j.issn.1006-1959.2024.07.023]
点击复制

基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年07期
页码:
120-123
栏目:
论著
出版日期:
2024-04-01

文章信息/Info

Title:
Study on Clinical Observation and Pharmaceutical Care of Patients with Chronic Heart Failure Based on the Platform of Clinical Pharmacists and Medical Alliance
文章编号:
1006-1959（2024）07-0120-04
作者:
程贵胜; 彭彩霞; 许 莺; 等
（修水县第一人民医院心血管内科1，药剂科2，院感办3，江西 修水 332400）
Author(s):
CHENG Gui-sheng; PENG Cai-xia; XU Ying; et al.
(Department of Cardiovascular Medicine1,Department of Pharmacy2,Hospital-Acquired Infection Control Department3,the First People’s Hospital of Xiushui County,Xiushui 332400,Jiangxi,China)
关键词:
临床药师; 医联体平台; 慢性心力衰竭; 药学监护
Keywords:
Clinical pharmacist; Medical alliance platform; Chronic heart failure; Pharmaceutical care
分类号:
R95
DOI:
10.3969/j.issn.1006-1959.2024.07.023
文献标志码:
A
摘要:
目的 观察基于临床药师和医联体平台对慢性心力衰竭患者用药与药学监护的效果。方法 选取2020年9月-2022年10月我院就诊的420例慢性心力衰竭患者为研究对象，采用随机数字表法分为对照组（n=210）和观察组（n=210）。对照组接受常规观察与治疗，观察组在对照组基础上给予基于医联体平台的临床药师监管，比较两组心功能指标[左心室舒张末期内径（LVEDD）、左室射血分数（LVEF）、每搏量（SV）、心脏指数（CI）]、自护能力、治疗费用、住院时间、再住院率、病死率、不良反应发生率。结果 观察组监管后LVEF、SV、CI高于对照组，LVEDD低于对照组（P＜0.05）；观察组监管后自理能力、用药依从性、对疾病相关知识认知评分均高于对照组（P＜0.05）；观察组治疗费用、住院时间均小于对照组（P＜0.05）；随访3个月，观察组再住院率、病死率均低于对照组（P＜0.05）；观察组不良反应发生率为4.76%，低于对照组的13.33%（P＜0.05）。结论 基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的效果确切，可改善患者心功能指标，降低不良反应发生率，提高自护能力，预防再住院，降低病死率，改善患者预后。
Abstract:
Objective To observe the clinical and pharmaceutical care effect of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance.Methods A total of 420 patients with chronic heart failure who were treated in our hospital from September 2020 to October 2022 were selected as the research objects. They were divided into control group (n=210) and observation group (n=210) by random number table method. The control group received routine observation and treatment, and the observation group was given clinical pharmacist supervision based on the medical alliance platform on the basis of the control group. The cardiac function indexes [left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), stroke volume (SV), cardiac index (CI)], self-care ability, treatment cost, hospitalization time, rehospitalization rate, mortality rate and incidence of adverse reactions were compared between the two groups.Results After supervision, LVEF, SV and CI in the observation group were higher than those in the control group, and LVEDD was lower than that in the control group (P<0.05). The scores of self-care ability, medication compliance and cognition of disease-related knowledge in the observation group were higher than those in the control group (P<0.05). The treatment cost and hospitalization time of the observation group were lower than those of the control group (P<0.05). After 3 months of follow-up, the rehospitalization rate and mortality rate of the observation group were lower than those of the control group (P<0.05). The incidence of adverse reactions in the observation group was 4.76%, which was lower than 13.33% in the control group (P<0.05).Conclusion The clinical observation and pharmaceutical care of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance are effective. It can improve the cardiac function index of patients, reduce the incidence of adverse reactions, improve self-care ability, prevent rehospitalization, reduce mortality and improve the prognosis of patients.

参考文献/References:

[1]席兰艳,郑萍,陈少尉,等.临床药师对心力衰竭患者肝损伤的原因分析与药学监护[J].中南药学,2018,16(8):1062-1065.[2]武丹威,韩爽,施楠楠,等.临床药师主导的慢性病管理在提高老年高血压患者对药物了解程度方面的作用[J].中国药房,2018,29(23):3251-3254.[3]潘金,刘梅霞,车峰远,等.临床药师参与慢性心力衰竭临床路径管理的效果评价[J].中国药房,2017,28(23):3277-3281.[4]于峰,雒道光,贺坤,等.药师与医护人员协作管理对降低心力衰竭医保患者再住院率和医疗费用的影响[J].中国心血管杂志,2017,22(3):206-209.[5]Leibovici OK,Freimark D,Freedman LS,et al.Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial[J].BMC Med,2017,15(1):90.[6]陈芊茜,许耀珑.临床药师参与中西医结合治疗慢性心力衰竭的效果评价[J].内蒙古中医药,2018,37(8):62-63.[7]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性心力衰竭基层诊疗指南(2019年)[J].中华全科医师杂志,2019,18(10):936-947.[8]Wolfson AM,Fong M,Grazette L,et al.Chronic heart failure management and remote haemodynamic monitoring[J].Heart,2018,104(23):1910-1919.[9]曹晶晶,戴付敏,赵淑娟,等.老年慢性心力衰竭患者服药依从性现状及其影响因素分析[J].中国新药与临床杂志,2021,40(1):40-44.[10]李景枫,陈文佳,迟锦玉,等.哈尔滨市老年慢性心力衰竭患者自我管理水平与自我效能的相关性分析[J].国际老年医学杂志,2021,42(1):15-19.[11]张晓燕,孙世龙,张慧芝,等.慢性心力衰竭患者口服药物的不良反应及药学监护要点分析[J].河南医学研究,2020,29(22):4055-4058.[12]周芳,贾暖,吴清兰,等.药物治疗管理服务在慢性心力衰竭患者中的应用效果评价[J].中国药事,2021,35(11):1307-1313.[13]周冰莹.基于健康生态学和医联体平台的慢性心力衰竭健康管理模式构建研究[D].南京:东南大学,2021.[14]胡文爽,张柠,封国生.医联体平台下慢性病患者对社区医疗服务的评价及其对就诊机构选择的影响研究[J].中国全科医学,2020,23(16):1982-1988.[15]张楠,张娜,鲁秀玲,等.医联体药师团队参与COPD患者长期用药安全评估管理工作模式的实践研究[J].中国药师,2018,21(3):441-444.[16]杨贤,张海霞,王皓,等. “医药护”一体化移动工作站在临床药师规范化培训中的应用:以心力衰竭患者为例[J].中国医院药学杂志,2022,42(9):950-953.[17]刘秀梅,华之卉,毛新奇,等.临床药师对老年心力衰竭合并房颤及肾功能不全患者地高辛中毒的药学监护[J].上海医药,2021,42(9):49-51,59.[18]琚娜娜,罗林,张娴,等.临床药师对射血分数保留的心力衰竭病人的药学服务[J].药学服务与研究,2020,20(3):178-182.[19]高森,郭冰丽.临床药师参与心力衰竭合并房颤患者的药学监护与用药优化[J].基层医学论坛,2018,22(4):466-468.[20]李代毅.心力衰竭30天再入院风险预测模型的构建及药物治疗管理平台的初步探索[D].重庆:重庆医科大学,2022.

相似文献/References:

[1]吴国才.临床药师参与1例社区获得性MRSA肺炎治疗的病例报告[J].医学信息,2018,31(21):190.[doi:10.3969/j.issn.1006-1959.2018.06.058]
[2]徐 冬.临床药学服务平台的构建与应用[J].医学信息,2018,31(24):22.[doi:10.3969/j.issn.1006-1959.2018.24.006]
　XU Dong.Construction and Application of Clinical Pharmacy Service Platform[J].Journal of Medical Information,2018,31(07):22.[doi:10.3969/j.issn.1006-1959.2018.24.006]
[3]罗宏丽,张伦会,王国俊,等.我院临床药师岗位培训招生现状及启发[J].医学信息,2019,32(18):107.[doi:10.3969/j.issn.1006-1959.2019.18.035]
　LUO Hong-li,ZHANG Lun-hui,WANG Guo-jun,et al.The Status Quo and Enlightenment of Clinical Pharmacist Post Training Enrollment in Our Hospital[J].Journal of Medical Information,2019,32(07):107.[doi:10.3969/j.issn.1006-1959.2019.18.035]
[4]董明伟.癌性疼痛规范化诊疗中临床药师的药学监护作用[J].医学信息,2020,33(11):151.[doi:10.3969/j.issn.1006-1959.2020.11.049]
　DONG Ming-wei.The Pharmacological Monitoring Function of Clinical Pharmacists in the Standardized Diagnosis and Treatment of Cancer Pain[J].Journal of Medical Information,2020,33(07):151.[doi:10.3969/j.issn.1006-1959.2020.11.049]
[5]万凌燕,朱 健,范永荣.临床药师参与肾衰竭患者抗感染药个体化给药的药学监护效果[J].医学信息,2024,37(14):146.[doi:10.3969/j.issn.1006-1959.2024.14.030]
　WAN Ling-yan,ZHU Jian,FAN Yong-rong.Pharmaceutical Care Effect of Clinical Pharmacists Participating in Individualized Administration of Anti-infective Drugs in Patients with Renal Failure[J].Journal of Medical Information,2024,37(07):146.[doi:10.3969/j.issn.1006-1959.2024.14.030]

更新日期/Last Update: 1900-01-01